Delay discounting and adjuvant endocrine therapy adherence in hormone receptor-positive breast cancer.

Jennifer E VaughnChesley AmmermannMaryam B LustbergWarren K BickelJeffrey S Stein

Published in: Health psychology : official journal of the Division of Health Psychology, American Psychological Association (2021)

DD is associated with direct-observation (pill count) measures of endocrine therapy adherence in HRBC survivors, suggesting it is a potential therapeutic target for improving adherence. This target is also amenable to intervention with EFT. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Keyphrases

positive breast cancer
randomized controlled trial
early stage
glycemic control
young adults
type diabetes
metabolic syndrome
skeletal muscle
adipose tissue
risk assessment
human health
climate change
bone marrow
drug induced